We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Single Molecule Sequencing Technology Brings Genomic Screening to the Clinical Lab

By LabMedica International staff writers
Posted on 15 Mar 2010
Technologies are beginning to emerge that will allow clinical laboratories to deliver genomic sequence data within a few hours rather than in the days or weeks that are currently required.

Life Technologies Corp. More...
(Carlsbad, CA, USA) has introduced its single molecule sequencing (SMS) technology, which uses Qdot nanocrystals as its core sequencing engine. Qdots are nanometer-sized semiconductor crystals designed for cellular imaging research and for the detection of individual protein molecules.

Qdots are combined with advanced imaging instruments such as the SOLiD system, which generates signals more than 100 times more powerful than other dye or fluorescence techniques. The new technology uses specially designed sequencing versions of Qdot nanocrystals, attached to proprietary DNA polymerase molecules.

The system monitors the real time incorporation of nucleotides into individual growing DNA strands. As nucleotides are incorporated, they are energized by photons transferred from the Qdot nanocrystal, generating a characteristic colored flash of fluorescence light. The system records the time and color series of these light flashes to determine the nucleotide sequence of each individual DNA strand.

A novel attribute of the system is reagent exchange, where individual Qdot polymerases and synthesized templates can be removed and replaced with new ones. This enables immobilized individual DNA templates to be sequenced several times in a recursive fashion, allowing for highly accurate reads with minimal sample preparation. Reagent exchange enables linking together of multiple long reads to enable virtually unlimited read lengths.

"We see our single molecule technology as the perfect complement to our SOLiD and capillary electrophoresis platforms. As these systems have been and continue to be instrumental in genomic discovery, this new technology will be ideal for settings in which rapid, highly accurate sequencing results are necessary,” said Kip Miller, president of the genetic systems division at Life Technologies. "Our investment in the development of this SMS system demonstrates our ongoing commitment to the entire DNA sequencing technology continuum.”

Related Links:
Life Technologies


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.